MedTrace Logo

QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy

NCT07466212 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 920

Last updated 2026-03-12

No results posted yet for this study

Summary

The goal of this observational study is to see how type 2 diabetes affects quality of life in cancer patients receiving immunotherapy. We want to know if patients with diabetes have a greater decline in quality of life over six months compared to those without. The main question we aim to answer is:

\- How does quality of life change over six months in patients with versus without diabetes?

Participants will complete quality-of-life surveys at the start, then at 3 and 6 months. This will help us see if diabetes adds extra challenges during cancer treatment

Conditions

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Christina B Ruhlmann, MD, PhD · Onkologisk afd R, OUH

  • Debbie M Madsen, MD · Onkologisk afd R, OUH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-10
Primary Completion
2027-10-01
Completion
2027-10-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07466212 on ClinicalTrials.gov